CCR3 and Familial prostate cancer: In contrast to prostate cancer cells, inhibition of CCR3 had no effect on the Ad-CM-directed migration of all but one cell line (20% inhibition in the breast cancer cell line MDA-MB231; Supplementary Fig. 4b).